Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Whistleblower Must Show Pfizer Provided Kickbacks In Off-Label Promotion

  • News

Executive Summary

A former Pharmacia & Upjohn executive may proceed with his off-label promotion suit against Pfizer, but he must show the company engaged in unlawful kickbacks, a federal judge ruled

You may also be interested in...



Qui Tam Litigation: Peter Rost Suit Fails As Others Thrive

While whistleblowers have been scoring big payouts in suits alleging off-label promotion and kickbacks, Peter Rost struck out in his seven-year suit against Pfizer.

Qui Tam Litigation: Peter Rost Suit Fails As Others Thrive

While whistleblowers have been scoring big payouts in suits alleging off-label promotion and kickbacks, Peter Rost struck out in his seven-year suit against Pfizer.

Supreme Court To Decide If Whistle Blowers Can Sue Based On State Data

The pharma industry had reason to cheer when the Supreme Court announced the next round of cases it would take up. Missing from the June 22 order list was a suit challenging reverse settlements between brand and generic manufacturers

Table

View full table

Related Content

Pink Sheet
Pink Sheet
Tags:
Latest Headlines

Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines

CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings

Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds

Drug Shortages, Inspections In Focus At US FDA Appropriations Hearing

See All
UsernamePublicRestriction

Register

PS050220

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By